Filing Flows › Caris Life Sciences (CAI) › Net income
Caris Life Sciences (CAI) net income by quarter
Caris Life Sciences' net income was $15.2M in Q3 2026 (third quarter 2026), -81% from Q4 2025. Over the last 3 quarters it ranged from $15.2M (Q3 2026) to $82.0M (Q4 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $15.2M | -81% | -37% |
| Q4 2025 | $82.0M | +237% | — |
| Q3 2025 | $24.3M | — | — |
Q3 2026 at a glance
Caris Life Sciences, Q3 2026: revenue $275M (+27% year over year), operating margin 7.0%, net earnings $15.2M, operating cash flow −$22.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Caris Life Sciences' net income?
Caris Life Sciences' net income was $15.2M in Q3 2026 (third quarter 2026), -81% from Q4 2025.
How has Caris Life Sciences' net income changed?
Over the last 3 quarters it ranged from $15.2M (Q3 2026) to $82.0M (Q4 2025).